Statement from the court-appointed officials at Nexperia

Statement of the court-appointed officials at Nexperia following the Enterprise Chamber’s judgment of 11 November 2026

• Enterprise Chamber confirms the court-appointed officials’ authority to explore long-term solutions for Nexperia and orders Wingtech not to interfere with the process.
• Market sounding will assess investor interest in a majority or minority stake; no decision has been taken to dilute Wingtech’s ownership interest.
• We will seek renewed constructive dialogue with Wingtech to support Nexperia’s future and preserve shareholder value.
• We will continue to oversee the company and management, with additional manufacturing capacity being developed in Malaysia, the Philippines and through third-party partners.

The Enterprise Chamber's, part of the Amsterdam Court of Appeal, latest judgment, issued on 11 November 2026, clarifies our authority and responsibilities and the steps we may take to support Nexperia’s future. We supported an Enterprise Chamber intervention because we consider that Wingtech’s actions, including court proceedings in Dongguan, sought to obstruct our work and Nexperia’s efforts to maintain operations and expand capacity.

 

Background

In October 2025 and February 2026, the Enterprise Chamber suspended Mr. Zhang as a director of Nexperia and appointed us to help oversee the company. Our respective roles are non-executive director with a decisive vote and administrator of all but one of the shares in Nexperia Holding. Since our appointment, our priorities have been to stabilise Nexperia’s operations and work with Wingtech towards an agreed long-term solution. We have been guided by the long-term interests of Nexperia as a whole, the preservation of shareholder value and the interests of customers, employees and other stakeholders.

Our efforts have been seriously complicated by the effective separation of Nexperia’s Chinese subsidiaries from the wider group. Those businesses are now controlled separately by Wingtech. In our assessment, this has harmed Nexperia’s business and significantly impacted shareholder value. To address the resulting supply chain disruption, we have supported management in developing additional capacity in Malaysia and the Philippines and through third-party manufacturing partners.

 

Discussions with Wingtech and ongoing assessment

At the same time, we spoke to Wingtech in relation to a long-term solution. Our discussions with Wingtech about possible solutions were intended to remain confidential, with an agreement that their contents would not be used in court. We therefore regret that Wingtech has referred to those discussions in the Dongguan proceedings and in public statements, including its shareholder update of 4 November 2026, and in ways that we believe misrepresent these discussions.

In particular, our objective is not to “expropriate” Wingtech, and we are not currently preparing a sale of a majority stake to outside investors or seeking to divide Nexperia into Chinese and non-Chinese businesses. The current separation within the group instead results from actions taken by Wingtech and Nexperia’s local management in China. The Enterprise Chamber in its 11 November 2026 ruling has confirmed that those actions by Wingtech undermine its earlier orders.

We take no position on the merits of government policies affecting Nexperia. We must, however, consider their practical consequences for the company. In our assessment, giving in to Wingtech’s current demand to regain control over Nexperia would create serious risks to Nexperia’s ability to continue operating, given export controls and other policies being introduced in several major countries where it does business. The Enterprise Chamber has confirmed that we may take these risks into account.

 

Market sounding

Against this background, we have decided to assess market interest in possible long-term solutions for Nexperia. We intend to explore potential investor interest in either a majority or a minority stake, alongside seeking feedback from customers, financing partners and other stakeholders, also taking into account the views expressed by Wingtech. No decision has currently been taken to reduce Wingtech’s ownership interest. The Enterprise Chamber has confirmed that this exploration falls within our authority and responsibilities and has ordered Wingtech not to interfere with the process.

As emphasized by the Enterprise Chamber, Wingtech has chosen to invest in Nexperia, which is a Dutch company governed by Dutch law. We of course recognise the authority of Chinese courts within their jurisdiction. At the same time, the Enterprise Chamber has confirmed that Wingtech should not seek to restrain Dutch proceedings concerning Nexperia, frustrate measures ordered by Dutch courts or unduly hinder the company’s worldwide operations and the capacity expansion needed following the effective separation of its Chinese businesses.

With the clarity provided by the Enterprise Chamber’s ruling, we hope to resume constructive discussions with Wingtech soon. Our aim remains a long-term solution that supports Nexperia’s future, protects its stakeholders and preserves shareholder value.

 

12 November 2026

Guido Dierick, court-appointed director

Arnold Croiset van Uchelen, court appointed shares administrator